HMBD-011
/ Hummingbird Biosci
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 12, 2023
Selective targeting of pathogenic auto-reactive VH4-34 B cells with a rationally developed anti-VH4-34 antibody offers a new therapeutic approach for autoimmune disorders (P768)
(IMMUNOLOGY 2023)
- "In vivo, HMBD-011 treatment resulted in rapid elimination of VH4-34+ antibodies and cells. In conclusion, HMBD-011 represents a promising precision therapy for VH4-34 driven autoimmune disorders."
Autoimmune Hemolytic Anemia • Complement-mediated Rare Disorders • Hematological Disorders • Immunology • Inflammatory Arthritis • Lupus • Systemic Lupus Erythematosus
1 to 1
Of
1
Go to page
1